CLINICAL ASSOCIATIONS OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND ITS TYPE 2 RECEPTOR IN SYSTEMIC SCLEROSIS

by R. T. Alekperov, L. P. Ananyeva, M. V. Cherkasova
Published 2018-11-01

The diagnostic value of serum IgG4 for the diagnosis of IgG4-related disease: and is that so great?

by E. V. Sokol, M. V. Cherkasova, A. V. Torgashina
Published 2019-03-01

Perception of Russian Politics in Galicia in Diaries and Memoirs of World War I Participants

by Yu. A. Zherdeva, E. I. Sumburova, M. V. Cherkasova
Published 2021-08-01

Current methods for laboratory diagnosis of rheumatoid arthritis

by A A Novikov, E N Aleksandrova, M V Cherkasova, E L Nasonov, A A Novikov, E N Aleksandrova, M V Cherkasova, E L Nasonov
Published 2010-02-01

Anti-Mullerian hormone in systemic lupus erythematosus

by Z. S. Alekberova, O. N. Egorova, R. G. Goloeva, M. V. Cherkasova
Published 2021-02-01

Dynamics of lymphocyte subpopulations, CD4+CD25+CD127- T regulatory cells in patients with rheumatoid arthritis during therapy with the rituximab biosimilar Acellbia

by A. S. Avdeeva, Yu. P. Rubtsov, M. V. Cherkasova, E. L. Nasonov
Published 2020-05-01

Time course of changes in the level of N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients with rheumatoid arthritis during therapy with an interleukin-6 receptor inhi...

by E. V. Gerasimova, T. V. Popkova, A. V. Martynova, M. V. Cherkasova, D. S. Novikova
Published 2019-11-01

Changes of cytokine profile measures during the treatment of rheumatoid arthritis with rituximab biosimilar (Acellbia, BIOCAD) and the original drug (MabThera, F. Hoffmann-La Roche...

by A. S. Avdeeva, A. S. Artyukhov, E. B. Dashinimaeva, M. V. Cherkasova, E. L. Nasonov
Published 2019-03-01

IMMUNOLOGICAL EFFECTS OF A RITUXIMAB BIOSIMILAR (ACELBIA, BIOCAD) IN PATIENTS WITH RHEUMATOID ARTHRITIS

by A. S. Avdeeva, M. V. Cherkasova, D. A. Kusevich, V. V. Rybakova, E. L. Nasonov
Published 2018-11-01

Association between a low baseline level of gene expression of energy metabolism in the blood and the development of clinical remission in response to tofacitinib therapy in patien...

by E. V. Chetina, A. M. Satybaldyev, G. A. Markova, E. Yu. Samarkina, M. V. Cherkasova
Published 2021-06-01

ROLE OF MATRIX METALLOPROTEINASE 3 IN PREDICTING THE EFFICIENCY OF THERAPY FOR EARLY RHEUMATOID ARTHRITIS: THE REMARCA TRIAL

by A. S. Avdeeva, E. N. Aleksandrova, D. E. Karateev, E. L. Luchikhina, M. V. Cherkasova, E. L. Nasonov
Published 2016-03-01

Relationship of the clinical efficiency of tocilizumab therapy to the serum level of matrix metalloproteinase-3 in patients with rheumatoid arthritis

by A S Avdeeva, E N Aleksandrova, A A Novikov, M V Cherkasova, E Iu Panasiuk, E L Nasonov
Published 2013-05-01

The Relationship of Antibodies to Modified Citrullinated Vimentin and Markers of Bone and Cartilage Destruction in Rheumatoid Arthritis

by A. S. Avdeeva, E. N. Aleksandrova, A. A. Novikov, A. V. Smirnov, M. V. Cherkasova, E. L. Nasonov
Published 2014-01-01

Safety and efficacy of 23-valent polysaccharide pneumococcal vaccine in patients with systemic lupus erythematosus

by G. M. Tarasova, B. S. Belov, M. V. Cherkasova, E. A. Aseeva, T. M. Reshetnyak, T. V. Popkova, N. M. Kosheleva
Published 2021-06-01

Impact of tocilizumab therapy on immunological parameters in patients with rheumatoid arthritis

by Anastasia Sergeyevna Avdeyeva, E N Aleksandrova, E Yu Panasyuk, A A Novikov, M V Cherkasova, E L Nasonov
Published 2012-06-01

Bone destruction in rheumatoid arthritis: role of autoantibodies

by Anastasia Sergeyevna Avdeyeva, E N Aleksandrova, A A Novikov, A V Smirnov, M V Cherkasova, E L Nasonov
Published 2013-06-01

THE CLINICAL AND DIAGNOSTIC VALUE OF ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES IN EARLY JUVENILEARTHRITIS

by S O Salugina, E S Fedorov, E N Aleksandrova, A A Novikov, M V Cherkasova, A A Baranov, Yu A Valogina
Published 2009-06-01

CLINICAL VALUE OF BAFF AND APRIL CONCENTRATIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS

by T. A. Panafidina, M. A. Sokhova, T. V. Popkova, M. V. Cherkasova, A. A. Novikov, E. N. Aleksandrova, E. L. Nasonov
Published 2016-07-01

Metabolic syndrome in rheumatoid arthritis: role of adiponectin (preliminary results)

by Yulia Nikolaevna Gorbunova, T V Popkova, L V Kondratyeva, D S Novikova, E N Aleksandrova, M V Cherkasova, E L Nasonov
Published 2013-11-01

The expression of interferon-stimulated genes (interferon “signature”) in patients with rheumatoid arthritis (Preliminary results)

by A. S. Avdeeva, E. V. Tchetina, M. V. Cherkasova, G. A. Markova, A. S. Artyuhov, E. B. Dashinimaev, E. L. Nasonov
Published 2021-01-01